Skip to main content
Log in

Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis

  • Inflammatory Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Behçet disease (BD) is manifested by recurrent acute iridocyclitis with hypopyon in the active phase, which regresses spontaneously. Hypopyon consists of inflammatory cells infiltrating the eye, with polymorphonuclear cells (PMNs) as the main component. The present study was conducted to investigate the apoptosis property of PMNs in BD patients with uveitis.

Methods

PMNs were purified from peripheral blood cells of BD patients with uveitis in the active or remission phase and were cultured for 12 hours. In some cultures, lipopolysaccharide (LPS), antagonistic anti-TNFα antibody, agonistic anti-Fas antibody, or Fas:Fc fusion protein was added. At the end of cultures, apoptotic cells were evaluated by Annexin V expression using flow cytometry.

Results

Spontaneous apoptosis of PMNs showed lower levels in the remission phase of BD-related uveitis compared with the active phase or healthy controls. The lower level of PMN apoptosis in the remission phase of uveitis in BD remained even by stimulation with LPS, anti-TNFα antibody, or Fas:Fc fusion protein, which was abolished in the presence of agonistic anti-Fas antibody.

Conclusions

In BD patients, the apoptosis of PMNs was reduced in the remission phase of uveitis and restored in the active phase, which arose from the apoptotic cell death in part via Fas-Fas ligand interaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Ciccia F, Giardina E, Triolo G (2000) Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behcet’s disease. Clin Exp Rheumatol 18:495–498

    PubMed  CAS  Google Scholar 

  2. Akdeniz N, Esrefoglu M, Keles MS, Karakuzu A, Atasoy M (2004) Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet’s disease. Ann Acad Med Singapore 33:596–599

    PubMed  CAS  Google Scholar 

  3. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012–2020

    PubMed  CAS  Google Scholar 

  4. Direskeneli H (2001) Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002

    Article  PubMed  CAS  Google Scholar 

  5. Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T (2001) Neutrophil activation in Behcet’s disease. Clin Exp Rheumatol 19:S19–S24

    PubMed  CAS  Google Scholar 

  6. Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet’s disease. Mediators Inflamm 11:87–93

    Article  PubMed  CAS  Google Scholar 

  7. Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet’s disease. Mediators Inflamm 11:87–93

    Article  PubMed  CAS  Google Scholar 

  8. Gorman AM, Zhivotovsky B, Orrenius S, Ceccatellis S (1999) Cytochrome c release and caspase-3 activation during colchicine-induced apoptosis of cerebellar granule cells. Eur J Neurosci 11:1067–1072

    Article  PubMed  CAS  Google Scholar 

  9. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189–1192

    Article  PubMed  CAS  Google Scholar 

  10. Hachiya O, Takeda Y, Miyata H, Watanabe H, Yamashita T, Sendo F (1995) Inhibition by bacterial lipopolysaccharide of spontaneous and TNF-alpha-induced human neutrophil apoptosis in vitro. Microbiol Immunol 39:715–723

    PubMed  CAS  Google Scholar 

  11. Homburg CH, Roos D (1996) Apoptosis of neutrophils. Curr Opin Hematol 3:94–99

    Article  PubMed  CAS  Google Scholar 

  12. International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080

    Google Scholar 

  13. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 3:738–743

    Article  PubMed  CAS  Google Scholar 

  14. Liles WC, Klebanoff SJ (1995) Regulation of apoptosis in neutrophils—Fas track to death? J Immunol 155:3289–3291

    PubMed  CAS  Google Scholar 

  15. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429–440

    Article  PubMed  CAS  Google Scholar 

  16. Ogawa T (1995) Neutrophil chemotaxis by polarization assay in Behcet’s disease and sarcoidosis. Nippon Ganka Gakkai Zasshi 99:696–702

    PubMed  CAS  Google Scholar 

  17. Qiao H, Sonoda KH, Ariyama A, Kuratomi Y, Kawano Y, Ishibashi T (2005) CXCR2 Expression on neutrophils is upregulated during the relapsing phase of ocular Behcet disease. Curr Eye Res 30:195–203

    Article  PubMed  CAS  Google Scholar 

  18. Saga T, Matsuda H (1985) Microtubules in neutrophils of patients with Behcet’s disease. Jpn J Ophthalmol 29:31–36

    PubMed  CAS  Google Scholar 

  19. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S (1996) Cytokines in Behcet’s disease. J Rheumatol 23:321–322

    PubMed  CAS  Google Scholar 

  20. Shimada K, Yaoita H, Shikano S (1971) Chemotactic activity for polymorphonuclear leucocytes of the aqueous humor in patients with Behcet’s disease. Nippon Ganka Gakkai Zasshi 75:2100–2105

    PubMed  CAS  Google Scholar 

  21. Smith JR, Hart PH, Standfield SD, Coster DJ, Wing SJ, Williams KA (2000) Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol 84:205–211

    Article  PubMed  CAS  Google Scholar 

  22. Sobel JD, Haim S, Obedeanu N, Meshulam T, Merzbach D (1977) Polymorphonuclear leucocyte function in Behcet’s disease. J Clin Pathol 30:250–253

    Article  PubMed  CAS  Google Scholar 

  23. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99:396–402

    PubMed  CAS  Google Scholar 

  24. Takeuchi A, Kobayashi K, Mori M, Hashimoto A (1986) Non-phagocytic beta-glucuronidase release in Behcet’s disease. Clin Exp Rheumatol 4:3–7

    PubMed  CAS  Google Scholar 

  25. Tanaka T, Yamakawa N, Koike J, Suzuki F, Ususi M (1999) Behcet’s disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm 7:69–74

    Article  PubMed  CAS  Google Scholar 

  26. Ureten K, Ertenli I, Ozturk MA, Kiraz S, Onat AM, Tuncer M, Okur H, Akdogan A, Apras S, Calguneri M (2005) Neutrophil CD64 expression in Behcet’s disease. J Rheumatol 32:849–852

    PubMed  CAS  Google Scholar 

  27. Yamada M, Murai Y, Mimura Y (1980) Neutrophil beta-glucuronidase activity in Behcet’s disease (author’s translation). Nippon Ganka Gakkai Zasshi 84:1099–1106

    PubMed  CAS  Google Scholar 

  28. Yamagami S, Kawashima H, Tsuru T, Yamagami H, Kayagaki N, Yagita H, Okumura K, Gregerson DS (1997) Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64:1107–1111

    Article  PubMed  CAS  Google Scholar 

  29. Yamashita S, Suzuki A, Yanagita T, Hirohata S, Kamada M, Toyoshima S (2000) Analysis of neutrophil proteins of patients with Behcet’s disease by two-dimensional gel electrophoresis. Biol Pharm Bull 23:519–522

    PubMed  CAS  Google Scholar 

  30. Yoshida T, Tanaka M, Sotomatsu A, Okamoto K, Hirai S (1998) Serum of Behcet’s disease enhances superoxide production of normal neutrophils. Free Radic Res 28:39–44

    Article  PubMed  CAS  Google Scholar 

  31. Zouboulis C, May T (2003) Pathogenesis of Adamantiades-Behcet’s disease. Adv Exp Med Biol 528:161–171

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Grant-in-Aid 17791258 for Scientific Research from the Japan Society for the Promotion of Science. We thank Kazumi Nagasawa for technical assistance in analyzing the apoptosis assay.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaru Takeuchi.

Additional information

Keita Fujimori and Keiko Oh-i contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujimori, K., Oh-i, K., Takeuchi, M. et al. Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis. Graefes Arch Clin Exp Ophthalmol 246, 285–290 (2008). https://doi.org/10.1007/s00417-007-0659-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-007-0659-5

Keywords

Navigation